This National Cancer Institute (NCI) Small Business Innovation Research (SBIR) cooperative agreement is for small businesses aiming to develop or enhance nanotechnology-based therapeutics and/or in vivo diagnostics for cancer. The grant supports pre-clinical optimization and rigorous testing of these applications against specific cancer types. Projects must be milestone-driven, with a clear path towards a commercial product. The primary goal is to advance discoveries through pre-clinical phases, enabling submission of an Investigational New Drug (IND) or Investigational Device Exemption (IDE) application to the Food and Drug Administration (FDA) by or shortly after the Phase II completion. NCI will assist awardees, including support from the Nanotechnology Characterization Laboratory. This FOA does not fund basic research, disease mechanism studies, or clinical trials.
Opportunity ID: 58109
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-10-286 |
| Funding Opportunity Title: | Cancer Diagnostic and Therapeutic Agents Enabled by Nanotechnology (SBIR [U43/U44]) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 21, 2010 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 08, 2013 |
| Current Closing Date for Applications: | Jul 08, 2013 |
| Archive Date: | Aug 08, 2013 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $150,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-10-286.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B1 | Adobe-Forms-B1 | PKG00021550 | Nov 07, 2010 | Jul 08, 2013 | View |
Package 1
Mandatory forms
58109 RR_SF424_1_2-1.2.pdf
58109 SBIR_STTR_Information_1_1-1.1.pdf
58109 RR_OtherProjectInfo_1_3-1.3.pdf
58109 RR_KeyPersonExpanded_1_2-1.2.pdf
58109 RR_Budget-1.1.pdf
58109 PerformanceSite_1_4-1.4.pdf
58109 PHS398_ResearchPlan_1_3-1.3.pdf
58109 PHS398_CoverPageSupplement_1_4-1.4.pdf
58109 PHS398_Checklist_1_3-1.3.pdf
Optional forms
58109 RR_SubawardBudget-1.2.pdf
58109 PHS_CoverLetter_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
